Tocilizumab vs bevacizumab in critically ill COVID-19 patients: Registry-based prospective study
- DOI
- 10.1177/14782715251394935
- Published
- 2025-11-12
- Container
- Journal of the Royal College of Physicians of Edinburgh
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/14782715251394935,
title = {Tocilizumab vs bevacizumab in critically ill COVID-19 patients: Registry-based prospective study},
author = {Yatendra Kumar Gupta and Raghubir S Khedar and Gulam Mateen Parihar and Anil Kumar Sharma and Pramod Sarwa and Rajeev Gupta},
year = {2025},
journal = {Journal of the Royal College of Physicians of Edinburgh},
doi = {10.1177/14782715251394935},
url = {https://doi.org/10.1177/14782715251394935}
}RIS
TY - JOUR TI - Tocilizumab vs bevacizumab in critically ill COVID-19 patients: Registry-based prospective study AU - Yatendra Kumar Gupta AU - Raghubir S Khedar AU - Gulam Mateen Parihar AU - Anil Kumar Sharma AU - Pramod Sarwa AU - Rajeev Gupta PY - 2025 JO - Journal of the Royal College of Physicians of Edinburgh DO - 10.1177/14782715251394935 UR - https://doi.org/10.1177/14782715251394935 ER -
APA
Gupta, Y. K., Khedar, R. S., Parihar, G. M., Sharma, A. K., Sarwa, P., & Gupta, R. (2025). Tocilizumab vs bevacizumab in critically ill COVID-19 patients: Registry-based prospective study. Journal of the Royal College of Physicians of Edinburgh. https://doi.org/10.1177/14782715251394935
Source records
- crossref · retrieved 2026-09-25T21:04:57.960Z